Determinants of mortality in patients undergoing cardiac resynchronization therapy: Baseline clinical, echocardiographic, and angioscintigraphic evaluation prior to resynchronization

PACE - Pacing and Clinical Electrophysiology

Volumn 28, Issue 12, 2005, Pages 1260-1270

  De Sisti, Antonio ^a,b,d   Toussaint, Jean François ^a,c   Lavergne, Thomas ^a   Ollitrault, Jacky ^a   Abergel, Eric ^a   Paziaud, Olivier ^a   Ait Said, Mina ^a   Sader, Raif ^b   Le Heuzey, Jean Yves ^a   Guize, Louis ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b Cardiology Unit   (France)

^c INSERM   (France)

^d NONE   (France)

Author keywords

Cardiac resynchronization; Dyssynchrony; Heart failure; Mortality; NYHA Class IV

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; POTASSIUM PERCHLORATE; PYROPHOSPHATE; SPIRONOLACTONE; TECHNETIUM 99M; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ADULT; AGED; AORTA; APPARATUS; ARTIFICIAL HEART PACEMAKER; CARDIAC RESYNCHRONIZATION THERAPY; CAUSAL ATTRIBUTION; CAUSE OF DEATH; CONGESTIVE CARDIOMYOPATHY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG USE; ECHOGRAPHY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE CONDUCTION; HEART VENTRICLE TACHYCARDIA; HOSPITAL READMISSION; HUMAN; LUNG ARTERY PRESSURE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PATIENT CODING; PREDICTION; PULMONARY VALVE; QRS COMPLEX; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCINTIANGIOGRAPHY; SURVIVAL RATE; SURVIVAL TIME; UNIVARIATE ANALYSIS; ANALYSIS OF VARIANCE; ARTICLE; CHI SQUARE DISTRIBUTION; DEFIBRILLATOR; ECHOCARDIOGRAPHY; HEART ATRIUM FIBRILLATION; HEART PACING; METHODOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SCINTISCANNING;

ADRENERGIC BETA-AGONISTS; AGED; ANALYSIS OF VARIANCE; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, DILATED; CHI-SQUARE DISTRIBUTION; DEFIBRILLATORS, IMPLANTABLE; DOBUTAMINE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 33645069456     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2005.00266.x     Document Type: Review

References (48)

1. Cazeau S, Leclercq C, Lavergne T, et al., Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001 344 : 873 880.
2. Auricchio A, Stellbrink C, Sack S, et al., Pacing Therapies in Congestive Heart Failure (PATH-CHF) Study Group. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002 39 : 2026 3033.
3. Abraham WT, Fisher WG, Smith AL, et al., MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002 346 : 1845 1853.
4. Molhoek SG, Bax JJ, van Erven L, et al. Effectiveness of resynchronization therapy in patients with end-stage heart failure. Am J Cardiol 2002 90 : 379 383.
5. Toussaint JF, Lavergne T, Kerrou K, etal. Basal asynchrony and resynchronization with biventricular pacing predict long-term improvement of LV function in heart failure patients. Pacing Clin Electrophysiol 2003 26 : 1 9.
6. Leclercq C, Victor F, Alonso C, et al. Comparative effects of permanent biventricular pacing for refractory heart failure in patients with stable sinus rhythm or chronic atrial fibrillation. Am J Cardiol 2000 85 : 1154 1156.
7. Molhoek SG, Bax JJ, Bleeker GB, et al. Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation. Am J Cardiol 2004 15 : 1506 1509.
8. Bradley DJ, Bradley EA, Baughman KL, et al. Cardiac resynchronization and death from progressive heart failure. A meta-analysis of randomized controlled trials. JAMA 2003 289 : 730 740.
9. Bristow MR, Saxon LA, Boehmer J, et al., Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004 350 : 2140 2150.
10. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005 352 : 1 11.
11. Pitzalis MV, Iacoviello M, Romito R, et al., Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J Am Coll Cardiol 2002 40 : 1615 1622.
12. Sogaard P, Egeblad H, Pedersen AK, Kim WY, Kristensen BO, Hansen PS, Mortensen PT. Sequential versus simultaneous biventricular resynchronization for severe heart failure: Evaluation by tissue Doppler imaging. Circulation 2002 106 : 2078 2084.
13. Sogaard P, Egeblad H, Kim WY, Jensen HK, Pedersen AK, Kristensen BO, Mortensen PT. Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy. J Am Coll Cardiol 2002 40 : 723 730.
14. Yu CM, Chau E, Sanderson JE, et al. Tissue Doppler echocardiography evidences of reverses remodeling and improves synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 2002 105 : 438 444.
15. Bax JJ, Marwick TH, Molhoek SG, et al. Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation. Am J Cardiol 2003 92 : 1228 1240.
16. Ritter F. Indication for permanent pacing and choice of pacemaker. In : Fisher W, Ritter P (eds Cardiac Pacing in Clinical Practice. Berlin, Springer Verlag, 1998, pp. 166 202.
17. Leclercq C, Cazeau S, Ritter P, et al. A pilot experience with permanent biventricular pacing to treat advanced heart failure. Am Heart J 2000 140 : 862 870.
18. Zannad F, Briancon S, Juilliere Y, Mertes PM, Villemot JP, Alla F, Virion JM, the EPICAL Investigators. Incidence, clinical and etiologic features, and outcome of advanced chronic heart failure: The EPICAL Study. J Am Coll Cardiol 1999 33 : 734 742.
19. Braunwald E, Zipes DP, Libby P. Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia, PA, W.B. Saunders Company, 2001, pp. 534 561.
20. Campana C, Gavazzi A, Berzuini C, et al. Predictors of prognosis in patients waiting heart transplantation. J Heart Lung Transplant 1993 12 : 756 765.
21. Uretsky BF, Sheahan RG. Primary prevention of sudden cardiac death in heart failure: Will the solution be shocking? J Am Coll Cardiol 1997 30 : 1589 1597.
22. Oechslin E, Brunner-LaRocca HP, Solt G, et al. Prognosis of medically treated patients referred for cardiac transplantation. Int J Cardiol 1998 64 : 75 81.
23. McAlister FA, Teo KK, Taher M, et al. Insights into the contemporary epidemiology and outpatient management of congestive heart failure. Am Heart J 1999 138 : 87 94.
24. Cowie MR, Wood DA, Coats AJ, Thompson SG, Suresh V, Poole-Wilson PA, Sutton GC. Survival of patients with a new diagnosis of heart failure: A population based study. Heart 2000 83 : 505 510.
25. Muntwyler J, Abetel G, Gruner C, Follath F. One-year mortality among unselected outpatients with heart failure. Eur Heart J 2002 23 : 1861 1866.
26. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999 341 : 709 717.
27. Paker M, Cohn J, on behalf of the Steering Committee and Membership of the Advisory Council to Improve Outcomes Nationwide in Heart Failure. Consensus recommendations for the management of chronic heart failure. Am J Cardiol 1999 83 (2A 1A 38A.
28. The CAPRICORN investigators. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: The CAPRICORN randomized trial. Lancet 2001 357 : 1385 1390.
29. Williams JF, Bristow MR, Fowler MB. Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart association task force on practice guidelines (Committee on evaluation and management of heart failure). Circulation 1995 92 : 2764 2784.
30. Cintron G, Johnson G, Francis G, Cobb F, Cohn JN. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 1993 87 (Suppl. VI VI17 VI23.
31. St. John Sutton M, Pfeffer MA, Plappert T, et al., for the SAVE Investigators. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effect of captopril. Circulation 1994 89 : 68 75.
32. Zaret BL, Wackers FJ, Terrin ML, Forman SA, Williams DO, Knatterud GL, Braunwald E. Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombotilytic therapy for acute myocardial infarction: Results of Thrombolysis in Myocardial Infarction (TIMI) phase II study. The TIMI Study Group. J Am Coll Cardiol 1995 26 : 73 79.
33. Yap Y, Duong T, Bland M. Left ventricular ejection fraction in the thrombolytic era remains a powerful predictor of long-term but not short-term all-cause, cardiac and arrhythmic mortality after myocardial infarction - A secondary meta-analysis of 2828 patients. Heart 2000 85 : 55.
34. Thohan V. Prognostic implication of echocardiography in advanced heart failure. Curr Opin Cardiol 2004 19 : 238 249.
35. Polak JF, Holman L, Wynne J, Colucci WS. Right ventricular ejection fraction: An indicator of increased mortality in patients with congestive heart failure associated with coronary artery disease. J Am Coll Cardiol 1983 2 : 217 224.
36. De Groote P, Millaire A, Foucher-Hossein C, et al. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. J Am Coll Cardiol 1998 32 : 948 954.
37. Ghio S, Gavazzi A, Campana C, et al. Independent et additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol 2001 37 : 183 188.
38. Xiao HB, Roy C, Fujimoto S, Gibson DG. Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy. Int J Cardiol 1996 53 : 163 170.
39. Shamin W, Francis DP, Yousufuddin M. Intraventricular conduction delay: A prognostic marker in chronic heart failure. Int J Cardiol 1999 70 : 171 178.
40. Baldasseroni S, Opasich C, Gorini M, et al., Italian Network on Congestive Heart Failure Investigators. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: A report from the Italian network on congestive heart failure. Am Heart J 2002 143 : 398 405.
41. Iuliano S, Fisher SG, Karasik PE, Fletcher RD, Singh SN, Department of Veterans Affairs Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. QRS duration and mortality in patients with congestive heart failure. Am Heart J 2002 143 : 1085 1091.
42. Vogt J, Krahnefeld O, Lamb B, et al. Electrocardiographic remodeling in patients paced for heart failure. J Am Coll Cardiol 2000 86 (Suppl. I K152 K156.
43. Leclercq C, Faris O, Tunin R, et al. Systolic improvement and mechanical resynchronization does not require electrical synchrony in the dilated failing heart with left bundle-branch block. Circulation 2002 106 : 1760 1763.
44. Bordachar P, Garrigue S, Lafitte S, Reuter S, Jais P, Haissaguerre M, Clementy J. Interventricular and intra-left ventricular electromechanical delays in right ventricular paced patients with heart failure: Implications for upgrading to biventricular stimulation. Heart 2003 89 : 1401 1405.
45. Leon AR, Greenberg JM, Kanuru N, et al., Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: Effect of upgrading to ventricular pacing after chronic right ventricular pacing. J Am Coll Cardiol 2000 86 (Suppl. I K152 K156.
46. Horwich T, Foster E, De Marco T, Tseng Z, Saxon L. Effects of resynchronization therapy on cardiac function in pacemaker patients "upgraded" to biventricular devices. J Cardiovasc Electrophysiol 2004 15 : 1284 1289.
47. De Sisti A, Lavergne T, Toussaint J-F, et al., In patients with dilated cardiomyopathy and ventricular dyssynchrony, upgrading to cardiac resynchronization therapy is as beneficial as de novo implant. Europace 2005 7 (Suppl. 1 58.
48. Makaty KJ, Dumitru I, Ewald Gl. Cardiac resynchronization therapy does not change mortality in Class IV CHF patients on continuous inotrope infusion with ICDs. Pacing Clin Electrophysiol 2003 26 : 1019.